Cyclosporine in the treatment of severe attack of ulcerative colitis: A systematic review

Gastroenterologia y Hepatologia

Volumn 28, Issue 10, 2005, Pages 607-614

  Garcia Lopez S ^a   Gomollon Garcia F ^b   Perez Gisbert J ^c  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; LIVER ENZYME; STEROID;

ABSCESS; ACUTE KIDNEY FAILURE; ADULT; BACTERIAL MENINGITIS; BONE MARROW SUPPRESSION; BRONCHOSPASM; CLINICAL TRIAL; COLON RESECTION; CONVULSION; DEATH; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; FEVER; GINGIVA HYPERPLASIA; HEADACHE; HERPES ZOSTER; HIRSUTISM; HUMAN; HYPERGLYCEMIA; INFECTION; NEPHROTOXICITY; NEUROTOXICITY; PARESTHESIA; PATIENT SELECTION; PNEUMONIA; REMISSION; REVIEW; SEPSIS; SIDE EFFECT; STEROID THERAPY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; VERTIGO; VOMITING;

EID: 30944433773     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5705(05)71523-5     Document Type: Article

References (47)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis: part one: short term prognosis. Gut. 1963;4:300-8.
2. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;4947:1041-8.
3. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974;1:1067-70.
4. Kornbluth A, Marion JF, Salomon P, Janowitz HD. How effective is current medical therapy for severe ulcerative colitis and Crohn's colitis? J Clin Gastroenterol. 1995;20:280-4.
5. Pearson DC, May GR, Fick G, Sutherland LR. Azatioprina para el mantenimiento de la remisión en la enfermedad de Crohn (Translated Cochrane Review). In: The Cochrane Library. Oxford: Update Software. CD000067-ES. CD000067-ES.
6. Gupta S, Keshavarzian A, Hodgson HJF. Cyclosporin in ulcerative colitis. Lancet. 1984;2:1277-8.
7. Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K. Cyclosporine A for induction of remission in severe ulcerative colitis. The Cochrane Database of Systematic Reviews 2005;1: CD004277.
8. McCormack G, McCormick PA, Hyland JM, O'Donoghue DP. Cyclosporin therapy in severe ulcerative colitis: is it worth the effort? Dis Colon Rectum. 2002;45:1200-5.
9. Rolny P, Sadik R. Longer term outcome of steroid refractory ulcerative colitis treated with intravenous cyclosporine without subsequent oral cyclosporine maintenance therapy. Int J Colorectal Dis. 2002;17:67-9.
10. Naftali T, Novis B, Pomeranz I, et al. Cyclosporin for severe ulcerative colitis. Isr Med Assoc J. 2000;2:588-91.
11. Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol. 2000;95:2000-8.
12. Haslam N, Hearing SD, Probert CSJ. Audit of cyclosporine use in inflammatory bowel disease: limited benefits, numerous side efffects. Eur J Gastro Hepatol. 2000;12:657-60.
13. Hermida-Rodríguez C, Cantero Perona J, García-Valriberas R, Pajares García JM, Mate-Jiménez J. High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease. Hepatogastroenterology. 1999;46:2265-8.
14. Gurudu SR, Griffel LH, Gialanella RJ, Das KM. Cyclosporine therapy in inflammatory bowel disease: short-term and long-term results. J Clin Gastroenterol. 1999;29:151-4.
15. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol. 1999;94:1587-92.
16. Actis GC, Aimo G, Priolo G, Moscato D, Rizzetto M, Pagni R. Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm Bowel Dis. 1998;4:276-9.
17. Stack WA, Long RG, Hawkey CJ. Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther. 1998;12:973-8.
18. Hyde GM, Thillainayagam AV, Jewell DP. Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol. 1998;10:411-3.
19. Wenzl HH, Petritsch W, Aichbichler BW, Hinterleitner TA, Fleischmann G, Krejs GJ. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis. Z Gastroenterol. 1998;36:287-93.
20. Van Gossum A, Schmit A, Adler M, et al, and the Belgian IBD Group. Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Acta Gastroenterol Belg. 1997;60:197-200.
21. Carbonnel F, Boruchowicz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci. 1996;41:2471-6.
22. Santos J, Baudet S, Casellas F, Guarner L, Vilaseca J, Malagelada JR. Efficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis. J Clin Gastroenterol. 1995;20:285-9.
23. Lichtiger S, Present D. Preliminary report: cyclosporine treatment of severe active ulcerative colitis. Lancet. 1990;336:16-9.
24. Rayner CK, McCormack G, Emmanuel AV, Kamm MA. Long term results of low dose intravenous ciclosporin for acute severe ulcerative colitis. Alimentary. 2003;18:303-8.
25. Castro B, Crespo J, García-Suárez C, Fábrega E, Casafont F, Pons-Romero F. Triple terapia inmunosupresora en el tratamiento de la colitis ulcerosa grave. Gastroenterol Hepatol. 2004;27:1-5.
26. D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology. 2001;120: 1323-9.
27. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330:1841-5.
28. Van Assche G, D'Haens G, Noma M, et al. Randomized, double blind comparision of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003;125:1025-31.
29. Svanoni F, Bonassi U, Bagnolo F, et al. Effectiveness of cyclopsorin A (CsA) in the treatment of active refractory ulcerative colitis (UC). Gastroenterology. 1998;114:A1096.
30. Sood A, Midha V, Sood N. Oral cyclosporine in patients with active severe ulcerative colitis not responding to steroids. Indian J Gastroenterol. 2002;21:155-6.
31. Daperno M, Sostegni R, Rocca R, et al. Review article: medical treatment of severe ulcerative colitis. Aliment Pharmacol Ther. 2002;16 Suppl 4:7-12.
32. Falasco G, Zinicola R, Forbes A. Review article: immunosuppressants in distal ulcerative colitis. Aliment Pharmacol Ther. 2002;16:181-7.
33. Navazo L, Salata H, Morales S, et al. Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis. J Scand J Gastroenterol. 2001; 36:610-4.
34. Ortiz V, Nos P, Aguilera V, Berenguer J, Ponce J. Cyclosporin in an oral microemulsion as the initial treatment of corticoid-refractory ulcerative colitis. Gastroenterol Hepatol. 2000;23:120-2
35. Actis GC, Volpes R, Rizzetto M. Oral microemulsion cyclosporin to reduce steroids rapidly in chronic activeulcerative colitis. Eur J Gastroenterol Hepatol. 1999;11:905-8.
36. Van Bodegraven AA, Linskens RK, Van Haelst IM, Sindram JW, Tuynman HA. Addition of low-dose oral cyclosporine in severe ulcerative colitis -pharmacokinetics and clinical outcome report of twelve cases. J Clin Gastroenterol. 1998;27:72-3.
37. Taylor AC, Connell WR, Elliott R, D'Apice AJ. Oral cyclosporin in refractory inflammatory bowel disease. Aust N Z J Med. 1998;28:179-83.
38. Stack WA, Richardson PD, Logan RP, Mahida YR, Hawkey CJ. Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine. Am J Gastroenterol. 2001;96:2255-6.
39. Caroli A, Fregonese D, Di Falco G, D'Inca R. Aspergillus fumigatus pneumonia during cyclosporine treatment for ulcerative colitis. Am J Gastroenterol. 2000;95:3016-7.
40. Hinterreiter M, Stadler B, Knoflach P. Recurrent septicemia with lethal outcome during and after cyclosporine therapy in severe ulcerative colitis. Acta Med Austriaca. 2000;27:91-3.
41. Quan VA, Saunders BP, Hicks BH, Sladen GE. Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia. BMJ. 1997;314:363-4.
42. Smith MB, Hanauer SB. Pneumocystis carinii pneumonia during cyclosporine therapy for ulcerative colitis. N Engl J Med. 1992;327:497-8.
43. Scottt A, Myers GA, Bruce A, Harms MD. Pneumocystis carinii pneumonia postrestorative prcotocolectomy for ulcerative colitis: a role for perioperative prophylaxis in the cyclosporine era? Dis Colon Rectum. 1997;40:973-6.
44. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet. 2004;363:1728-31.
45. Kamm MA. Antagonist: early surgical intervention in ulcerative colitis. Gut. 2004;53:308-9.
46. Cima RR, Pemberton JH. Antagonist: early surgical intervention in ulcerative colitis. Gut. 2004;53:306-7.
47. Domènech E, García-Planella E, Bernai I, et al. Azathioprine without oral cyclosporin in the long-term maintenance of remission induced by intravenous cyclosporin in severe, steroid-refractory ulcerative colitis. Aliment Pharmacol Ther. 2002;16: 2061-5.